These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7383075)

  • 21. [Hypertension therapy with metoprolol--comparison between single and double doses].
    Callans A; Dafgård T; Jäderberg E; Lindahl T; Sandefeldt A
    Lakartidningen; 1979 Apr; 76(17):1628-30. PubMed ID: 449458
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of metoprolol in the treatment of constant essential hypertension].
    Peltier JM
    LARC Med; 1982; 2(7):611-2. PubMed ID: 7167036
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monotherapy of uncomplicated essential hypertension with metoprolol].
    Mahlke R; Kühns K
    Med Welt; 1980 Feb; 31(9):333-5. PubMed ID: 7374428
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypotensive effect of metoprolol].
    Cybulska I; Brym E; Czerniewska E; Sznajderman M
    Pol Tyg Lek; 1982 Jun; 37(18):535-7. PubMed ID: 6757898
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of metoprolol in the management of hypertension.
    Chia BL; Teoh PC; Tan NB; Ee B
    Singapore Med J; 1979 Sep; 20(3):373-7. PubMed ID: 505035
    [No Abstract]   [Full Text] [Related]  

  • 26. A multicentre study of cardioselective metoprolol (Lopresor) and non-selective propranolol in the management of mild to moderate hypertension.
    Browning RC; Ebbutt A; Russell JG; Mayhew SR
    Br J Clin Pract; 1981; 35(11-12):399-402. PubMed ID: 7306448
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of beta blockade on contingent negative variation in migraine.
    Maertens de Noordhout A; Timsit-Berthier M; Timsit M; Schoenen J
    Ann Neurol; 1987 Jan; 21(1):111-2. PubMed ID: 3827211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antihypertensive effect of metoprolol in essential hypertension].
    Rodríguez Rodríguez FJ; Petersen Guitarte G; Paumard Fraguas A; López-Vidriero E; Franco Manera R
    Med Clin (Barc); 1983 Mar; 80(8):358-61. PubMed ID: 6855321
    [No Abstract]   [Full Text] [Related]  

  • 29. [New selective beta 1-receptor antagonist. A comparison of metoprolol (Seloken) and placebo in mild to moderate hypertension].
    Andreassen PH; Drivenes A
    Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1081-3, 78. PubMed ID: 333653
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metoprolol in the treatment of essential hypertension (author's transl)].
    Salgueiro Rodríguez M; Pérez Pombo S; Beiras García E
    Med Clin (Barc); 1981 Feb; 76(3):121-4. PubMed ID: 7206875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
    Strandgaard S; Elmgreen J; Christensen TE; Laursen SW
    Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
    [No Abstract]   [Full Text] [Related]  

  • 32. [Regression of left ventricular hypertrophy by a prolonged anti-hypertensive treatment].
    Sonaglioni G; Floris B; Franchetta G; Palestini N; Verdecchia P
    G Ital Cardiol; 1982; 12(6):428-35. PubMed ID: 6219030
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug treatment of essential hypertension. Practical guidelines.
    Dirix R; Savoye D; Tyberghein JM
    Practitioner; 1979 May; 222(1331):713-6. PubMed ID: 482222
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect on mortality of metoprolol in acute myocardial infarction. A randomized double-blind trial (author's transl)].
    Hjalmarson A; Elmfeldt D; Herlitz J; Holmberg S; Málek I; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wihelmsson C
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):32-45. PubMed ID: 6799780
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol].
    Ardjah H
    Med Welt; 1980 Sep; 31(37):1326-30. PubMed ID: 7432128
    [No Abstract]   [Full Text] [Related]  

  • 39. Metoprolol for hypertension. Open trial in general practice.
    Fredman RM
    Med J Aust; 1982 Oct; 2(8):378-80. PubMed ID: 6755204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two year clinical evaluation of atenolol and metoprolol in the treatment of hypertension.
    Trafford JA; McGonigle R; Bowles J; O'Neal H; Bennet-Jones DN; Halford L
    Br J Clin Pract; 1982 Oct; 36(10):350-2. PubMed ID: 6756448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.